Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3793-3795

  Aliberti, Camillo ^a,c   Tilli, M ^a   Benea, G ^a   Fiorentini, G ^b  

^a AUSL Ferrara   (Italy)

^b SAN GIUSEPPE HOSPITAL   (Italy)

^c Department of Interventional Radiology Delta Hospital ^*  (Italy)

Author keywords

Chemoembolization; Colorectal cancer; Drug eluting beads; Irinotecan; Liver metastases

Indexed keywords

IRINOTECAN;

ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; DRUG TOLERABILITY; HUMAN; LIVER METASTASIS; PAIN; PRIORITY JOURNAL; TRANSARTERIAL CHEMOEMBOLIZATION;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; DRUG CARRIERS; HUMANS; LIVER NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750722420     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Stangl R, Altendorf-Hofmann A, Charnley RM et al: Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405-1410, 1994.
2. Weiss L: Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195-203, 1986.
3. Takats PG and Kerr DJ: Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Eur J Cancer 32A: 2201-2205, 1996.
4. Pitot HC and Wender DB, O'Connell MJ et al: Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 15: 2910-2919, 1997.
5. Chen HS and Gross JF: Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31-40, 1980.
6. Ensminger WD and Gyves JW: Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 10: 176-182, 1983.
7. Van Riel JMGH, Van Groeningen CJ, De Greve J et al: Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 15: 59-63, 2004.
8. Fiorentini G, Rossi S, Dentico P et al: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study.Tumori 89: 382-384, 2003.
9. Van Riel JMGH, Van Groeningen CJ, Kedde MA et al: Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study. Clin Cancer Res 8: 405-412, 2002.
10. Hong K, Kobeiter H, Georgiades CS et al: Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. JVIR 16: 1711-1717, 2005.
11. Lewis AL, Gonzalez MV, Lloyd AW et al: DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17: 335-342, 2006.
12. Hong K, Khwaja A, Liapi E et al: New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12: 2563-2567, 2006.